Although lithium remains the preferred medication for bipolar disorder
s, new investigations suggest that only 60 to 80% of patients have a g
ood response with a classical presentation. The antiepileptics carbama
zepine and valproate are important alternatives. Several studies have
shown that lithium, carbamazepine and valproate are effective in pure
mania. Mixed mania and rapid cycling respond, however, well to valproa
te. One disadvantage of carbamazepine is its enzyme inducing property
with the consequence of a decrease of plasma levels of other psychotro
pic medications and a worsening of psychopathology. First data indicat
e a good antimanic and antidepressive efficacy of the new antiepilepti
c drug lamotrigine.